Didier Pelaprat

Title: The Innovations of Didier Pelaprat

Introduction

Didier Pelaprat is a notable inventor based in Paris, France. He has made significant contributions to the field of medical research, particularly in the development of neurotensin analogues. His work focuses on targeting neurotensin receptor-positive tumors, which are prevalent in various types of cancers.

Latest Patents

Didier Pelaprat holds a patent for "Neurotensin analogues for radioisotope targeting to neurotensin receptor-positive tumors." This invention relates to a new neurotensin analogue, or a salt thereof, that is useful for targeting tumors such as ductal pancreatic adenocarcinoma, exocrine pancreatic cancer, invasive ductal breast cancers, colon adenocarcinoma, small cell lung carcinoma, Ewing sarcoma, meningioma, medulloblastoma, and astrocytoma. He has 1 patent to his name.

Career Highlights

Throughout his career, Didier Pelaprat has worked with esteemed organizations, including the National Institute of Health and Medical Research and Iason GmbH. His experience in these institutions has allowed him to advance his research and contribute to significant medical innovations.

Collaborations

Didier has collaborated with notable colleagues such as Anne Gruaz and Jacques Barbet. Their combined expertise has furthered the development of innovative solutions in the medical field.

Conclusion

Didier Pelaprat's work in developing neurotensin analogues showcases his commitment to advancing cancer treatment. His contributions are vital in the ongoing fight against various forms of cancer, and his innovations continue to inspire future research.